Published in Am J Hum Genet on September 01, 1997
A combined analysis of genomewide linkage scans for body mass index from the National Heart, Lung, and Blood Institute Family Blood Pressure Program. Am J Hum Genet (2002) 1.87
Meta-analysis of linkage data under worst-case conditions: a demonstration using the human OB region. Genetics (1998) 1.64
Quantitative-trait loci influencing body-mass index reside on chromosomes 7 and 13: the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet (2001) 1.59
Genome scan for human obesity and linkage to markers in 20q13. Am J Hum Genet (1999) 1.58
A locus on mouse Chromosome 9 (Adip5) affects the relative weight of the gonadal but not retroperitoneal adipose depot. Mamm Genome (2006) 0.87
Genetic association study of selected candidate genes (ApoB, LPL, Leptin) and telomere length in obese and hypertensive individuals. BMC Med Genet (2009) 0.80
Comparison between two analytic strategies to detect linkage to obesity with genetically determined age of onset: the Framingham Heart Study. BMC Genet (2003) 0.75
A general model for the genetic analysis of pedigree data. Hum Hered (1971) 40.17
Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 38.85
Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet (1995) 12.78
Identification and expression cloning of a leptin receptor, OB-R. Cell (1995) 9.74
Analysis of family resemblance. 3. Complex segregation of quantitative traits. Am J Hum Genet (1974) 9.68
Abnormal splicing of the leptin receptor in diabetic mice. Nature (1996) 7.71
A unified model for complex segregation analysis. Am J Hum Genet (1983) 5.67
Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res (1985) 5.22
Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes (1994) 4.66
Linkage analysis and family classification under heterogeneity. Ann Hum Genet (1983) 3.76
Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med (1989) 3.31
Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med (1993) 3.14
Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti gene. FASEB J (1994) 2.27
Association of Trp64Arg mutation of the beta3-adrenergic-receptor with NIDDM and body weight gain. Diabetologia (1996) 2.22
Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med (1995) 1.99
Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med (1995) 1.88
Human genes involved in lipolysis of plasma lipoproteins: mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21. Genomics (1987) 1.79
The human beta 3-adrenoceptor: the search for a physiological function. Trends Pharmacol Sci (1994) 1.76
Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med (1995) 1.70
Comparison of the 15q deletions in Prader-Willi and Angelman syndromes: specific regions, extent of deletions, parental origin, and clinical consequences. Am J Med Genet (1990) 1.53
Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler Thromb (1993) 1.45
Estimation of genetic model parameters: variables correlated with a quantitative phenotype exhibiting major locus inheritance. Genet Epidemiol (1989) 1.40
The Prader-Willi syndrome. Arch Dis Child (1994) 1.39
The genetic and environmental sources of body mass index variability: the Muscatine Ponderosity Family Study. Am J Hum Genet (1991) 1.37
Molecular structure and chromosomal mapping of the human homolog of the agouti gene. Proc Natl Acad Sci U S A (1994) 1.30
Quantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7. Am J Hum Genet (1996) 1.22
Multifactorial genetic models for quantitative traits in humans. Biometrics (1979) 1.19
Variance components/major locus likelihood approximation for quantitative, polychotomous, and multivariate data. Genet Epidemiol (1993) 1.15
A procedure for combining two-point lod scores into a summary multipoint map. Hum Hered (1993) 1.14
Linkage between obesity and a marker near the tumor necrosis factor-alpha locus in Pima Indians. J Clin Invest (1995) 1.13
Indication for linkage of the human OB gene region with extreme obesity. Diabetes (1996) 1.10
The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes (1996) 1.09
Common major gene inheritance of extreme overweight. Hum Biol (1990) 1.09
A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun (1995) 1.08
Extreme obesity may be linked to markers flanking the human OB gene. Diabetes (1996) 1.08
Influence of genotype-dependent effects of covariates on the outcome of segregation analysis of the body mass index. Am J Hum Genet (1993) 1.07
Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun (1995) 1.05
Major gene with sex-specific effects influences fat mass in Mexican Americans. Genet Epidemiol (1995) 1.04
Absence of mutations in the human OB gene in obese/diabetic subjects. Diabetes (1996) 1.03
Absence of linkage of obesity and energy metabolism to markers flanking homologues of rodent obesity genes in Pima Indians. Diabetes (1996) 0.97
Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res (1993) 0.96
Obesity in Pima Indians: genetic segregation analyses of body mass index complicated by temporal increases in obesity. Hum Biol (1994) 0.95
Major gene effect for insulin levels in familial NIDDM pedigrees. Diabetes (1992) 0.94
Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest (1993) 0.93
Physiological and metabolic consequences of obesity. Metabolism (1995) 0.93
Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest (1990) 0.93
Evidence for a major gene for type II diabetes and linkage analyses with selected candidate genes in Mexican-Americans. Diabetes (1996) 0.92
Identification of microsatellite markers near the human ob gene and linkage studies in NIDDM-affected sib pairs. Diabetes (1995) 0.89
Phenotypic characterization of the Trp64Arg polymorphism in the beta 3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia (1996) 0.89
Pharmacological characterization of a recently described human beta 3-adrenergic receptor mutant. Endocrinology (1996) 0.89
Assignment of the gene encoding glycogen synthase (GYS) to human chromosome 19, band q13.3. Genomics (1993) 0.87
Correcting for single ascertainment by truncation for a quantitative trait. Am J Hum Genet (1988) 0.87
Human obesity does not segregate with the chromosomal regions of Prader-Willi, Bardet-Biedl, Cohen, Borjeson or Wilson-Turner syndromes. Int J Obes Relat Metab Disord (1995) 0.86
Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med (1993) 0.85
Mutation screening and identification of a sequence variation in the human ob gene coding region. Biochem Biophys Res Commun (1996) 0.83
Segregation analysis of height-adjusted weight with generation- and age-dependent effects: the Nancy Family Study. Genet Epidemiol (1992) 0.83
Absence of linkage between human obesity and the mouse agouti homologous region (20q11.2) or other markers spanning chromosome 20q. Obes Res (1995) 0.83
Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes. Circulation (1996) 0.83
Molecular scanning of the glycogen synthase and insulin receptor substrate-1 genes in Japanese subjects with non-insulin-dependent diabetes mellitus. Biochem Biophys Res Commun (1994) 0.82
Role of the beta 3-adrenergic receptor locus in obesity and noninsulin-dependent diabetes among members of Caucasian families with a diabetic sibling pair. J Clin Endocrinol Metab (1996) 0.81
Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people. Int J Obes Relat Metab Disord (1995) 0.81
DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin-dependent) diabetes mellitus. Atherosclerosis (1995) 0.80
Prediction of adult skinfolds and body mass from infancy through adolescence. Ann Hum Biol (1995) 0.79
Simple tandem repeat DNA polymorphism in the human glycogen synthase gene is associated with NIDDM in Japanese subjects. Diabetologia (1994) 0.79
Analysis of CA repeat polymorphisms places three human gene loci on the 8p linkage map. Cytogenet Cell Genet (1996) 0.78
Human obese gene: molecular screening in Japanese and Asian Indian NIDDM patients associated with obesity. Diabetes (1996) 0.78
Linkage analysis of 19 candidate regions for insulin resistance in familial NIDDM. Diabetes (1995) 0.78
Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med (1993) 0.78
Polymorphism of the glycogen synthase gene in hypertensive and normotensive subjects. Hypertension (1996) 0.77
Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1993) 0.77
Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT4 genes in NIDDM. Diabetes (1994) 0.77
Description of a second microsatellite marker and linkage analysis of the muscle glycogen synthase locus in familial NIDDM. Diabetes (1994) 0.76
A novel amino acid substitution (His183-->Gln) in exon 5 of the lipoprotein lipase gene results in loss of catalytic activity: phenotypic expression of the mutant gene in a heterozygous state. J Lipid Res (1994) 0.76
The glycogen synthase gene in NIDDM and hypertension. Diabetologia (1995) 0.76
Inheritance of extreme overweight in black families. Hum Biol (1991) 0.76
Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families. J Clin Endocrinol Metab (1994) 0.76
First protein kinase structure. Science (1991) 9.25
Antigen processing: a new pathway discovered. Science (1992) 5.85
Discovery of a cool planet of 5.5 Earth masses through gravitational microlensing. Nature (2006) 3.53
Lack of association between early exposure to cow's milk protein and beta-cell autoimmunity. Diabetes Autoimmunity Study in the Young (DAISY) JAMA (1996) 3.52
Monoclonal antibodies to human cytomegalovirus: three surface membrane proteins with unique immunological and electrophoretic properties specify cross-reactive determinants. Infect Immun (1982) 3.40
Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia (1996) 3.23
The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell (1993) 2.99
Evidence for increased recombination near the human insulin gene: implication for disease association studies. Proc Natl Acad Sci U S A (1986) 2.96
Yeast biology enters a surprising new phase. Science (1992) 2.70
The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology (2001) 2.68
Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell (1991) 2.48
NHLBI family blood pressure program: methodology and recruitment in the HyperGEN network. Hypertension genetic epidemiology network. Ann Epidemiol (2000) 2.28
The prevalence of primary angle closure glaucoma and open angle glaucoma in Mamre, western Cape, South Africa. Arch Ophthalmol (1993) 2.18
A genome-wide search for type 2 diabetes susceptibility genes in Utah Caucasians. Diabetes (1999) 1.99
'Men leave me as I cannot have children': women's experiences with involuntary childlessness. Hum Reprod (2002) 1.88
Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol (1993) 1.87
Complement-fixing antibody in human sera reactive with viral and soluble antigens of cytomegalovirus. J Clin Microbiol (1975) 1.81
Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol (2001) 1.79
Polymorphism of human cytomegalovirus glycoproteins characterized by monoclonal antibodies. Virology (1984) 1.76
Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron (1992) 1.75
Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system. J Thromb Haemost (2004) 1.72
Pilot study of the effectiveness of the family-to-family education program. Psychiatr Serv (2001) 1.71
Electrophoretic analysis of polypeptides immune precipitated from cytomegalovirus-infected cell extracts by human sera. Infect Immun (1982) 1.71
Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J Clin Endocrinol Metab (1996) 1.69
Incidence of bronchoconstriction due to aspirin, azo dyes, non-azo dyes, and preservatives in a population of perennial asthmatics. J Allergy Clin Immunol (1979) 1.66
Multiple restriction fragment length polymorphisms at the insulin receptor locus: a highly informative marker for linkage analysis. Proc Natl Acad Sci U S A (1986) 1.59
Variants in the 5q31 cytokine gene cluster are associated with psoriasis. Genes Immun (2007) 1.59
Genome-wide association and meta-analysis in populations from Starr County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and enrichment for expression quantitative trait loci in top signals. Diabetologia (2011) 1.59
Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein. Proc Natl Acad Sci U S A (1993) 1.58
Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care (1998) 1.58
Sleep benefit in Parkinson's disease. Mov Disord (1997) 1.56
Restoring hemostatic thrombin generation at the time of cutaneous wounding does not normalize healing in hemophilia B. J Thromb Haemost (2007) 1.56
Generation of species cross-reactive aptamers using "toggle" SELEX. Mol Ther (2001) 1.49
Alpha-macroglobulin secreted by alveolar macrophages serves as a binding protein for a macrophage-derived homologue of platelet-derived growth factor. Am J Respir Cell Mol Biol (1989) 1.48
Bloom syndrome: an analysis of consanguineous families assigns the locus mutated to chromosome band 15q26.1. Proc Natl Acad Sci U S A (1994) 1.46
Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2. J Clin Invest (1998) 1.46
The cell's nucleus shapes up. Science (1993) 1.45
Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family. Hum Mol Genet (1997) 1.44
Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol (1997) 1.43
The remineralizing effect of an essential oil fluoride mouthrinse in an intraoral caries test. J Am Dent Assoc (2004) 1.42
Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis. Ann Neurol (1993) 1.41
Analysis of antibody assay methods and classes of viral antibodies in serodiagnosis of cytomegalovirus infection. J Clin Microbiol (1978) 1.41
EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness. Epilepsy Res (1994) 1.40
Platelets contain releasable coagulation factor IX antigen. Blood Coagul Fibrinolysis (1993) 1.39
Hormone replacement therapy--finally, good data. S Afr Med J (2004) 1.39
HIV test counselling at a tertiary hospital. S Afr Med J (1995) 1.39
Cardiopulmonary support in the intensive care unit. Am J Crit Care (1992) 1.38
[Bactericide activity of sulbactam before bacteria belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex]. Enferm Infecc Microbiol Clin (1996) 1.38
BAT-26 and BAT-40 instability in colorectal adenomas and carcinomas and germline polymorphisms. Am J Pathol (1999) 1.36
A DNA probe for the LDL receptor gene is tightly linked to hypercholesterolemia in a pedigree with early coronary disease. Am J Hum Genet (1986) 1.32
Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function. Mov Disord (1998) 1.31
Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease. Aliment Pharmacol Ther (2007) 1.29
Human glucagon-like peptide-1 receptor gene in NIDDM. Identification and use of simple sequence repeat polymorphisms in genetic analysis. Diabetes (1994) 1.28
Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity. Am J Hum Genet (1993) 1.26
Autosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA4): clinical description and genetic localization to chromosome 16q22.1. Am J Hum Genet (1996) 1.25
Etiological heterogeneity in X-linked spastic paraplegia. Am J Hum Genet (1987) 1.25
Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif. J Immunol (1993) 1.24
A mutation in the insulin receptor gene that impairs transport of the receptor to the plasma membrane and causes insulin-resistant diabetes. EMBO J (1989) 1.24
Variants of the VDR gene and risk of colon cancer (United States). Cancer Causes Control (2001) 1.24
Effect of the microencapsulation of nanoparticles on the reduction of burst release. Int J Pharm (2007) 1.24
Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol (1997) 1.22
Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy. Neuromuscul Disord (2001) 1.19
Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification. Int J Pharm (1999) 1.18
Misoprostol for second trimester pregnancy termination in women with prior caesarean: a systematic review. BJOG (2009) 1.13
Genome-wide linkage analysis of lipids in the Hypertension Genetic Epidemiology Network (HyperGEN) Blood Pressure Study. Arterioscler Thromb Vasc Biol (2001) 1.13
The application of genomic and proteomic technologies in predictive, preventive and personalized medicine. Vascul Pharmacol (2006) 1.13
High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system. Br J Haematol (2001) 1.12
Effect of acriflavine and sodium dodecyl sulphate on infectiveness of Rhizobium trifolii. Acta Microbiol Pol A (1973) 1.11
Modifiable risk factors for Type 2 diabetes mellitus in a peri-urban community in South Africa. Diabet Med (1999) 1.11
Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol (1999) 1.10
Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians. Diabetes (1996) 1.09
Stimulation of 5-fluorouracil metabolic activation by interferon-alpha in human colon carcinoma cells. Biochem Biophys Res Commun (1992) 1.09
New polymorphisms at the insulin locus increase its usefulness as a genetic marker. Diabetes (1985) 1.09
The GENNID Study. A resource for mapping the genes that cause NIDDM. Diabetes Care (1996) 1.08
The 45XO/46XY mosaic intersex syndrome. J Med Genet (1966) 1.07
Infertility in South Africa: women's reproductive health knowledge and treatment-seeking behaviour for involuntary childlessness. Hum Reprod (2002) 1.06
Beta-cell autoantibodies in infants and toddlers without IDDM relatives: diabetes autoimmunity study in the young (DAISY). J Autoimmun (1996) 1.05
Outcomes of the peer-taught 12-week family-to-family education program for severe mental illness. Acta Psychiatr Scand (2004) 1.05
Gastric duplication cyst communicating with aberrant pancreatic duct: a rare cause of recurrent acute pancreatitis. Surgery (1987) 1.05
Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations. Am J Hematol (2000) 1.05
Community participation in the Mamre Community Health Project. S Afr Med J (1988) 1.05
Sequence variants in the pancreatic islet beta-cell inwardly rectifying K+ channel Kir6.2 (Bir) gene: identification and lack of role in Caucasian patients with NIDDM. Diabetes (1997) 1.04
Preparation and characterization of nanoparticles containing an antihypertensive agent. Eur J Pharm Biopharm (1998) 1.03
No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia (2011) 1.03
Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide). Biomaterials (1996) 1.02
Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives. Am J Epidemiol (2000) 1.02
Adrenergic receptor polymorphisms associated with resting heart rate: the HyperGEN Study. Ann Hum Genet (2006) 1.01
Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int J Pharm (2000) 1.00
Circulating tissue factor accumulates in thrombi, but not in hemostatic plugs. J Thromb Haemost (2006) 0.99
Challenges in implementing a cervical screening program in South Africa. Cancer Detect Prev (2006) 0.99
Feasibility of using genetic linkage analysis to identify the genes encoding T cell-defined minor histocompatibility antigens. Tissue Antigens (2002) 0.99
A possible mechanism of action of activated factor VII independent of tissue factor. Blood Coagul Fibrinolysis (1998) 0.99
Preparation and characterization of ethylcellulose microspheres containing 5-fluorouracil. J Microencapsul (1995) 0.98
Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy. J Control Release (1999) 0.97
Transmission of a procoagulant signal from tissue factor-bearing cell to platelets. Blood Coagul Fibrinolysis (1996) 0.96
Cytomegalovirus-infected cell polypeptides immune-precipitated by sera from children with congenital and perinatal infections. Infect Immun (1983) 0.96
Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study. Arterioscler Thromb Vasc Biol (2000) 0.96
Insulin gene in diabetes. Analysis through RFLP. Diabetes Care (1990) 0.95